Design of noncovalent trypsin inhibitor based on the X-ray crystal structure of the complex. 1995

M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
Osaka University of Pharmaceutical Sciences, Japan.

The inhibitory mechanism of trans-4-aminomethylcyclohexanecarbonyl-L-phenyl-alanine-4-carbo xymethylanilide (1), a noncovalent serine protease inhibitor synthesized based on previous structure-activity studies, was clarified based on the X-ray crystal structure of the complex (2.2 A resolution, R = 0.175), where the amino group of the aminomethylcyclohexane moiety was bifurcately hydrogen-bonded to the carboxyl oxygens of Asp 189 side group (specificity pocket), and the hydrogen bonds of the cyclohexanecarbonyl oxygen to NHs of Gly 193 and Ser 195 residues (oxyanion hole) and of Phe NH to Ser 195 O gamma atom (catalytic triad) were observed. In contrast, the Phe benzene moiety and terminal carboxymethylanilide of 1 were not well located on the electron density map, suggesting the conformational freedom of these P1' and P2' sites at the binding pocket. Based on these insights, trans-4-aminomethylcyclohexanecarbonyl-4-nitro-L-phenylalanine-4-+ ++benzoylanilide (2) was designed, in which the P1' and P2' sites were modified so as to effectively interact with the amino acid residues of trypsin binding pocket via hydrogen bonding and van der Waals interactions, respectively. Consequently, 2 showed 40 times higher inhibitory activity against trypsin than 1.

UI MeSH Term Description Entries
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D014361 Trypsin Inhibitors Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. Trypsin Inhibitor,Inhibitor, Trypsin,Inhibitors, Trypsin
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
February 1992, FEBS letters,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
June 1989, Journal of biochemistry,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
January 2004, Biochemical and biophysical research communications,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
June 2013, Journal of medicinal chemistry,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
July 2014, Journal of natural products,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
April 2000, Biological chemistry,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
January 1998, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
September 1998, European journal of biochemistry,
M Nakamura, and K Tomoo, and T Ishida, and H Taguchi, and Y Tsuda, and Y Okada, and A Okunomiya, and K Wanaka, and S Okamoto
September 1998, Journal of medicinal chemistry,
Copied contents to your clipboard!